Libo Pharma Corp. (TPEX:7888)

Libo Pharma Statistics

Total Valuation

Libo Pharma has a market cap or net worth of TWD 3.61 billion. The enterprise value is 3.28 billion.

Market Cap	3.61B
Enterprise Value	3.28B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Libo Pharma has 75.24 million shares outstanding.

Current Share Class	75.24M
Shares Outstanding	75.24M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	7.61
P/TBV Ratio	11.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.76
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.98

Financial Position

The company has a current ratio of 6.38, with a Debt / Equity ratio of 0.00.

Current Ratio	6.38
Quick Ratio	5.89
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-4,669.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-47.13%
Revenue Per Employee	n/a
Profits Per Employee	-11.10M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.51
Average Volume (20 Days)	581,491

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-224.11M
Pretax Income	-221.94M
Net Income	-221.94M
EBITDA	-202.70M
EBIT	-224.11M
Earnings Per Share (EPS)	-5.43

Balance Sheet

The company has 337.66 million in cash and 2.20 million in debt, with a net cash position of 335.45 million or 4.46 per share.

Cash & Cash Equivalents	337.66M
Total Debt	2.20M
Net Cash	335.45M
Net Cash Per Share	4.46
Equity (Book Value)	474.85M
Book Value Per Share	10.99
Working Capital	308.66M

Cash Flow

In the last 12 months, operating cash flow was -162.24 million and capital expenditures -1.74 million, giving a free cash flow of -163.97 million.

Operating Cash Flow	-162.24M
Capital Expenditures	-1.74M
Free Cash Flow	-163.97M
FCF Per Share	-2.18

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Libo Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.15%
FCF Yield	-4.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1